Inadvertent sub-macular triamcinolone during pars plana vitrectomy for epiretinal membrane: A case report
T. Erakgün, H.H. Gobeka Kaşkaloğlu Eye Hospital, Izmir, Türkiye. hgobeka@gmail.com
BACKGROUND: The study aims to describe an inadvertent sub-macular triamcinolone acetonide (TA) deposition following a TA-assisted pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling.
CASE REPORT: In this interventional case report, a 75-year-old female with ERM-induced visual distortion underwent TA-assisted 25-gauge three-port PPV, endolaser photocoagulation, and sulfur hexafluoride (SF6) gas (8%) endo tamponade to treat ERM in the left eye. Significant TA deposition was observed intraoperatively in the submacular region, which remained after ERM and internal limiting membrane (ILM) removal. One month after PPV, the retina appeared flat, with no significant vitreoretinal interface defects or macular ultrastructural abnormalities. Vision improved from 0.40 to 0.2 logMAR, and there was no evidence of any ophthalmoscopic damage.
CONCLUSIONS: Inadvertent sub-macular TA deposition following ERM peeling did not cause any significant surgical sequelae.
Graphical Abstract


This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
T. Erakgün, H.H. Gobeka
Inadvertent sub-macular triamcinolone during pars plana vitrectomy for epiretinal membrane: A case report
Eur Rev Med Pharmacol Sci
Year: 2025
Vol. 29 - N. 5
Pages: 225-230
DOI: 10.26355/eurrev_202505_37221
Publication History
Submission date: 20 Jan 2025
Revised on: 20 Mar 2025
Accepted on: 22 Apr 2025
Published online: 28 May 2025